Accept Cookies

This website uses cookies to help us know a little bit about you, how you use our website and improve the browsing experience. Manage cookies.

Skip to main content

RX-Info News & Views

News & Views

18 April 2019

Rx-info returns to CPC to help NHS hospital pharmacists with medicines reporting

Posted in News

Medicines Reporting Q&A for hospital pharmacists at CPC – June 7th & 8th 2019
The team from Rx-Info will be at this year’s Clinical Pharmacy Congress at ExCeL London on June 7th & 8th 2019 and available to answer any queries relating to medicines reporting in NHS secondary care.
Since spring 2019, all NHS secondary care pharmacies across England and Wales are equipped with Rx-info software packages, enabling them to gather rich intelligence on their medicines stocks; including usage, performance, movement and cost.
Colin Richman, Jonathan Kerr, Beth Simmons, Sophie Leach, Jason Pruchniewicz and Bethany Perriton-Branch will be at Stand A25 with information and support relating to their hospital pharmacy software including:
Define® – which enables organisations to benchmark their drug activity against peers (cost and usage) and
Adios ® – which identifies accountability within the Trust and the movement of abusable drugs
Refine ® – which enables drug usage to be monitored and accounted for within an individual hospital trust
Exend ® – which monitors purchasing and stock levels; providing information on consumption rates and forecasting of stock surpluses or…

Read more
Rx-info returns to CPC to help NHS hospital pharmacists with medicines reporting
22 January 2019

Mapping to Virtual Medicinal Product Pack

Posted in News

Rx-info maps all descriptions received from Trusts each month, with 92% of the total drug descriptions mapped to the dm+d. The remainder are manufactured items, items not yet listed on dm+d or items…

Read more
22 January 2019

Biosimilars: adalimumab

Posted in News

As has been widely reported in the press, adalimumab is now available in a range of biosimilar products and NHSE has issued guidance on the use of the new biosimilars. Products from Amgen…

Read more
22 January 2019

Hepatitis C antivirals – cost comparison

Posted in News

NICE is proposing a quality standard for treatment of hepatitis C but in the interim the newer antivirals for treating the different genotypes of hepatitis C are covered by Technology Appraisal…

Read more
22 January 2019

Drug description – unit clarification

Posted in News

There are a few instances for each Trust where it has not been possible to map the Trust description to dm+d as the information supplied is not sufficient to identify the intended product or pack…

Read more

Find out how we can help you

Contact Us